Cancer Cause and Prevention Research in Pennsylvania
Cancer Cause and Prevention Research (93.393) awarded $175 million to recipients in Pennsylvania in 133 grants from fiscal 2021 to 2025, 4.8% of the program's national total. The Trustees of the University of Pennsylvania received the most, $57.2 million.
- Awarded in Pennsylvania$175 million
- Awards133
- Share of the program4.8%
- Rank among states5th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 67 | $29.4 million |
| FY 2022 | 75 | $35.6 million |
| FY 2023 | 76 | $39.8 million |
| FY 2024 | 76 | $34.2 million |
| FY 2025 | 68 | $35.7 million |
Recipients in Pennsylvania
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Trustees of the University of Pennsylvania | Colleges and universities | 44 | $57.2 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Other | 31 | $46.6 million |
| Pennsylvania State University | Other | 12 | $15.2 million |
| The Children's Hospital of Philadelphia | Nonprofits | 6 | $11.7 million |
| The Institute for Cancer Research | Nonprofits | 9 | $11.7 million |
| Ecog-Acrin Medical Research Foundation, Inc. | Nonprofits | 2 | $9.5 million |
| The Pennsylvania State University | Other | 6 | $6.1 million |
| The Wistar Institute of Anatomy and Biology | Nonprofits | 3 | $4.8 million |
| Thomas Jefferson University | Colleges and universities | 7 | $4.1 million |
| Geisinger Clinic | Nonprofits | 2 | $3.2 million |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Pennsylvania?
$175 million from fiscal 2021 to 2025, across 133 awards. Pennsylvania ranks 5th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Pennsylvania?
The largest recipient is The Trustees of the University of Pennsylvania, with $57.2 million in 44 awards. Next are University of Pittsburgh - of the Commonwealth System of Higher Education and Pennsylvania State University.
Can organizations in Pennsylvania apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Pennsylvania
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Federal Transit Formula Grants
- Special Education Grants to States
- Child Care and Development Block Grant